Former chief executive of CytoDyn and the CEO of a company that managed its clinical trials allegedly made fraudulent claims about experimental drug

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

University of Phoenix students to get nearly $50 million in false ad settlement

Nearly $50 million is being sent to former University of Phoenix students…

Supreme Court sides with doctors convicted in pain pill schemes

WASHINGTON — The Supreme Court on Monday ruled for doctors who face criminal…

Bank Profits Fell 6% Last Year as War, Inflation and Higher Rates Hurt Results

Markets Finance Total ranks as second-best on record; recession fears drive rise…

A bride and her dad who went viral with their dance share a special bond

A bride and her father have danced their way into the internet’s…